Akrinor versus phenylephrin for the treatment of maternal hypotension during caesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025795

Enrollment

800

Registered

2021-07-16

Start date

2021-01-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I95.2

Interventions

Group 1: The treatment of the maternal SPA induced hypotension was in the group phenylephrine. Pheylephrin was routinely started with .5 µg/kgBW/min i.v. after the injection of local anesthetic (pheyl

Eligibility

Sex/Gender

Female

Age

12 Years to 70 Years

Inclusion criteria

Inclusion criteria: pregnancy and sectio caesarea in spinal anesthesia

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
maternal hypotension, fetal pH and BE	—

Secondary

Measure	Time frame
heart beat, volume recusitation, use of rescue medication, blood loss	—

Countries

Germany

Contacts

Public ContactMartin Schick

Universitätsklinikum Freiburg

martin.schick@uniklinik-freiburg.de0761 270 23051

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026